Susquehanna International »

Lineage Cell Therapeutics In shares owned by Susquehanna International

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $52k 35k 1.48
2023-09-30 $17k 15k 1.18
2023-06-30 $58k 41k 1.41
2023-03-31 $1.2M 816k 1.50
2022-12-31 $203k 174k 1.17
2022-09-30 $92k 81k 1.13
2022-06-30 $274k 172k 1.59
2022-03-31 $314k 204k 1.53
2021-12-31 $1.2M 498k 2.44
2021-09-30 $1.8M 725k 2.53
2021-06-30 $852k 299k 2.85
2021-03-31 $2.7M 1.1M 2.35
2020-12-31 $1.1M 607k 1.76
2020-09-30 $44k 47k 0.94
2020-06-30 $35k 40k 0.87
2020-03-31 $80k 96k 0.83
2019-12-31 $53k 59k 0.89
2019-09-30 $95k 98k 0.97